Home > Newsletters > FDAnews Drug Daily Bulletin > FDA Warns on Counterfeit Adderall Entering U.S. Via Internet Pharmacies
FDAnews Drug Daily Bulletin
June 8, 2012 | Vol. 9 No. 113
FDA Warns on Counterfeit Adderall Entering U.S. Via Internet Pharmacies
Rogue online pharmacies looking to cash in on drugs in short supply are peddling counterfeit versions of Teva’s attention-deficit/hyperactivity disorder drug Adderall, the FDA warns. Teva discovered the sales of Adderall (dextroamphetamine/amphetamine) 30-mg tablets containing the wrong active ingredients when patients alerted the company to errors in product packaging, Teva spokeswoman Denise Bradley said.
Washington Drug Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.